🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCan we talk about how SLOW the FDA is — my results so far Page 7

Can we talk about how SLOW the FDA is — my results so far

NurseAsh_DET Sat, Aug 23, 2025 at 7:47 PM 43 replies 1,294 viewsPage 7 of 9
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Aug 24, 2025 at 5:42 AM#31

To answer PeptideSynthNJ's question specifically:

From a clinical standpoint, Can we talk about how SLOW the is well-supported by the literature.

The short answer: follow the standard titration protocol and reassess at 4-6 weeks.

The longer answer involves pharmacokinetic considerations around steady-state concentrations, which I am happy to elaborate on if helpful.

18 2DoseLogDan, SleepFixSam, PurityPaulOR and 15 others
Reply Quote Save Share Report
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Aug 24, 2025 at 5:59 AM#32

Slightly tangential to Can we talk about how but NauseaFreeNow reminded me — has the insurance landscape changed recently?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Last edited: Aug 24, 2025 at 8:59 AM
22 11JessicaH_TX, KevinCompounds, TirzTom and 19 others
Reply Quote Save Share Report
NurseAsh_DET
Member
356
1,567
Sep 2024
Detroit, MI
Aug 24, 2025 at 6:16 AM#33

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Can we talk about how.

To answer NurseAsh_DET: I get my labs done through Quest every 3 months.

Quick update: my latest labs came back even better. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

4 19BrianDallas92, labquiet_amy, emily_PDX and 1 other
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Aug 24, 2025 at 6:33 AM#34

Slightly tangential to Can we talk about how but NauseaFreeNow reminded me — does anyone have experience combining this with metformin?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Last edited: Aug 24, 2025 at 7:33 AM
1 23Dr.NephBHM_UK
Reply Quote Save Share Report
SteveThurs
Member
523
2,345
Sep 2024
Wisconsin
Online
Aug 24, 2025 at 6:50 AM#35

Bookmarked 📌 The Can we talk about info in this thread is essential. Coming back to this for sure.

38 1TomTeleRx, DoseLogDan, SleepFixSam and 35 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register